First in-human trial of novel therapy was presented at the American Heart Association’s Scientific Sessions 2023
SELECT trial presented by Cleveland Clinic physician at the American Heart Association’s Scientific Sessions 2023
Patient is the first at the center to receive the drug outside of clinical research for the treatment of mild Alzheimer’s disease
Program to foster access to first quantum computer in healthcare, collaboration with researchers
Program will initially be used for specialty and rush medications starting in 2025
Technology invented by Cleveland Clinic researchers, made by Prevent Biometrics
WATCH TAVR trial presented at the Transcatheter Cardiovascular Therapeutics annual conference